JNJ

Johnson & Johnson

Jan 30 • 04:00PM ET

227.25

-0.04 -0.02 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO IVV SPY VTV XLV VIG VYM DIA IWD

Index	DJIA, S&P 500	P/E	20.57	EPS (ttm)	11.05	Insider Own	0.12%	Shs Outstand	2.41B	Perf Week	3.23%
Market Cap	547.51B	Forward P/E	18.12	EPS next Y	12.54	Insider Trans	-9.95%	Shs Float	2.41B	Perf Month	9.83%
Enterprise Value	574.75B	PEG	2.19	EPS next Q	2.69	Inst Own	74.24%	Short Float	0.89%	Perf Quarter	21.78%
Income	26.80B	P/S	5.81	EPS this Y	7.20%	Inst Trans	0.20%	Short Ratio	2.40	Perf Half Y	37.94%
Sales	94.19B	P/B	6.90	EPS next Y	8.45%	ROA	13.54%	Short Interest	21.33M	Perf YTD	9.81%
Book/sh	32.95	P/C	29.50	EPS next 5Y	8.26%	ROE	33.62%	52W High	230.00 -1.20%	Perf Year	50.35%
Cash/sh	7.70	P/FCF	27.94	EPS past 3/5Y	17.88% 14.90%	ROIC	22.58%	52W Low	141.50 60.60%	Perf 3Y	34.06%
Dividend Est.	5.31 (2.34%)	EV/EBITDA	18.45	Sales past 3/5Y	5.57% 2.67%	Gross Margin	75.27%	Volatility	1.38% 1.79%	Perf 5Y	36.91%
Dividend TTM	5.14 (2.26%)	EV/Sales	6.10	EPS Y/Y TTM	71.07%	Oper. Margin	27.43%	ATR (14)	3.78	Perf 10Y	134.88%
Dividend Ex-Date	Feb 24, 2026	Quick Ratio	0.80	Sales Y/Y TTM	6.05%	Profit Margin	28.46%	RSI (14)	77.15	Recom	2.07
Dividend Gr. 3/5Y	4.92% 5.25%	Current Ratio	1.07	EPS Q/Q	48.39%	SMA20	5.27%	Beta	0.34	Target Price	236.83
Payout	46.59%	Debt/Eq	0.58	Sales Q/Q	9.08%	SMA50	8.19%	Rel Volume	1.25	Prev Close	227.29
Employees	139800	LT Debt/Eq	0.50	Earnings	Jan 21 BMO	SMA200	26.46%	Avg Volume	8.88M	Price	227.25
IPO	Sep 25, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.12% 1.72%	Trades		Volume	11,045,529	Change	-0.02%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$262
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$230
Oct-20-25	Upgrade	Daiwa Securities	Neutral → Outperform	$203
Oct-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-23-25	Upgrade	Guggenheim	Neutral → Buy	$206
Jul-23-25	Upgrade	Erste Group	Hold → Buy
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$153
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170

Show Previous Ratings

Jan-31-26 07:35PM	Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist (Motley Fool)
12:35PM	Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy? (Insider Monkey)
Jan-30-26 10:38PM	This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? (Motley Fool)
08:28AM	What Are Wall Street Analysts' Target Price for Johnson & Johnson Stock? (Barchart)
Jan-29-26 06:32PM	US judge tosses lawsuit accusing J&J of fraud over talc bankruptcy strategy (Reuters)
04:06PM	Loading…
04:06PM	1 Dividend King to Buy and Hold Through Any Market (Barchart)
12:45PM	Scotiabank Raises Johnson & Johnson (JNJ) Target on Strong Quarterly Results (Insider Monkey)
12:42PM	This Winning Fund Pro Likes J&J, Lowe's, and Utility Stocks (Barrons.com)
11:52AM	HALO Rises Nearly 4% on Strong 2025 Preliminary Data and 2026 Guidance (Zacks)
09:41AM	PayPal downgraded, UPS upgraded: Wall Streets top analyst calls (TipRanks)
09:13AM	Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results (Zacks)
07:12AM	Johnson & Johnson Stock Rises After Morgan Stanley Upgrade (GuruFocus.com)
03:55AM	The Zacks Analyst Blog Johnson & Johnson, Netflix, Arista Networks, Omega and AXIL (Zacks)
Jan-28-26 05:02PM	Top Stock Reports for Johnson & Johnson, Netflix & Arista Networks (Zacks)
01:25PM	Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years (Motley Fool)
12:07PM	Loading…
12:07PM	UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs (Benzinga)
11:10AM	Should You Stay Invested in J&J Stock After Q4 Beat & Solid Guidance? (Zacks)
10:21AM	Texas Instruments, Circle, Johnson & Johnson: Top Analyst Calls (Yahoo Finance Video)
10:15AM	Merck's Non-Oncology Drugs Q4 Performance: What to Expect (Zacks)
09:39AM	PayPal downgraded, UPS upgraded: Wall Street's top analyst calls (The Fly)
07:48AM	CMS selects next batch of 15 high-cost medicines for third negotiation cycle (Pharmaceutical Technology)
06:25AM	3 Dividend Stocks to Hold for the Next 20 Years (Motley Fool)
05:51AM	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle (Benzinga)
Jan-27-26 03:49PM	DARZALEX FASPRO-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible (PR Newswire)
02:51PM	3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers (Zacks)
10:51AM	J&J Targets $100B+ Sales in 2026 as Growth Accelerates in Both Units (Zacks)
08:00AM	Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile (Business Wire)
05:22AM	Guggenheim Lifts Johnson & Johnson (JNJ) Outlook After Solid Q4 and 2026 Guide (Insider Monkey)
05:20AM	JNJ Delivers Strong 2026 Guidance Even as Policy Costs Loom (Insider Monkey)
05:00AM	5 robotic surgery trends to watch in 2026 (MedTech Dive)
02:37PM	Loading…
Jan-26-26 02:37PM	J&J Snack Foods CEO Dan Fachner on Dippin Dots Acquisition: ICR Conference 2026 (Exec Edge)
02:10PM	The 3 Dividend Stocks I Think Every Investor Should Own Right Now (24/7 Wall St.)
09:50AM	Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock (Zacks)
09:01AM	Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus (Zacks)
09:00AM	Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-24-26 02:20PM	2 Under-the-Radar Biotech Stocks Set to Boom in 2026 (Motley Fool)
Jan-23-26 12:52PM	ETFs to Buy Post JNJ's Q4 Earnings Surprise & Bullish Cash Flow View (Zacks)
12:50PM	2 Soaring Stocks to Hold for the Next 20 Years (Motley Fool)
11:24AM	Johnson & Johnson Quietly Triggers a Trend Following Buy Signal (MarketBeat)
11:07AM	Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. (Barrons.com)
09:45AM	Johnson & Johnson price target raised to $250 from $222 at TD Cowen (TipRanks)
08:44AM	Social Security Faces 24% Benefit Cut in 2032 Without Congressional Action (24/7 Wall St.)
08:14AM	Earnings live: Intel stock drops, Capital One stock falls on Brex acquisition (Yahoo Finance)
07:59AM	Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. (Barrons.com)
07:30AM	Pharma: J&J's broadening product pipeline can bring 'new era' (Yahoo Finance Video)
07:26AM	A 75-Year-Old Holds NVIDIA and 4 Dividend StocksShould He Simplify Now? (24/7 Wall St.)
05:04AM	Is This Dividend King a Screaming Buy? (Motley Fool)
Jan-22-26 04:42PM	Earnings live: Intel stock drops, GE Aerospace tumbles, Capital One announces Brex acquisition (Yahoo Finance)
02:35PM	I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. (Motley Fool)
12:03PM	ABBV vs. MRK: An Oncology-Immunology Showdown for Investors (Zacks)
11:45AM	Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio (Zacks)
11:19AM	Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. (Barrons.com)
10:08AM	Playing It Safe at 70 With $2.5 Million Is Likely To Backfire (24/7 Wall St.)
09:59AM	Jim Cramer on Johnson & Johnson: "One of the Best Pharmas There Is" (Insider Monkey)
09:15AM	Is BMY's Deep Pipeline the Key to Its Next Growth Phase? (Zacks)
09:04AM	A Couples $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate Reality (24/7 Wall St.)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:19AM	Earnings live: GE Aerospace orders surge, Procter & Gamble and Abbott stocks dip (Yahoo Finance)
06:38AM	Johnson & Johnson reports 9.1% increase in sales for Q4 2025 (Pharmaceutical Business Review)
02:05AM	This 2.4%-Yielding Dividend King Remains As Healthy As Ever (Motley Fool)
Jan-21-26 09:50PM	Is This Dividend King Stock a Buy After a Major Development? (Motley Fool)
07:07PM	J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll (Investor's Business Daily)
05:00PM	Stocks to Watch Wednesday Recap: Netflix, Schwab, J&J, United Airlines (The Wall Street Journal)
04:42PM	These Stocks Are Todays Movers: Intel, Netflix J&J, GameStop, Kraft Heinz, Schwab, and More (Barrons.com)
04:30PM	Johnson & Johnson (JNJ) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
04:26PM	Earnings live: Netflix stock tumbles, Johnson & Johnson falls, Charles Schwab climbs (Yahoo Finance)
04:20PM	Johnson & Johnson (JNJ) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:07PM	Analyst Report: Johnson & Johnson (Morningstar Research)
04:02PM	Johnson & Johnson (JNJ) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
04:00PM	Stock market today: Dow surges nearly 600 points, S&P 500, Nasdaq jump as Trump backs off Greenland tariff threats (Yahoo Finance)
04:00PM	Stock market today: Dow surges 550 points, S&P 500, Nasdaq jump as Trump backs off Greenland tariff threats (Yahoo Finance)
02:36PM	Stock Market Today: S&P 500 Higher After Trump Davos News; Johnson & Johnson Slides (Live Coverage) (Investor's Business Daily)
02:24PM	Johnson & Johnson Tops Earnings Estimates and Issues a Solid Outlook. The Stock Falls. (Barrons.com)
02:04PM	Stocks to Watch Wednesday: Netflix, Schwab, J&J, United Airlines (The Wall Street Journal)
01:57PM	Stocks Rebound On Trump's Remarks, Natural Gas Rockets: What's Moving Markets Wednesday? (Benzinga)
01:54PM	Johnson & Johnson Sees 2026 Profit, Sales Beating Wall Street Forecasts (GuruFocus.com)
12:33PM	Stock market today: Dow, S&P 500, Nasdaq jump as Trump says US, NATO have 'framework' of a deal for Greenland (Yahoo Finance)
12:33PM	Stock market today: Dow, S&P 500, Nasdaq jump after brutal sell-off as Trump rules out force on Greenland (Yahoo Finance)
12:14PM	Johnson & Johnson Q4 Earnings Call Highlights (MarketBeat)
12:00PM	Johnson & Johnson Talc Plaintiffs Clear Key Expert Testimony Hurdle (Benzinga)
11:41AM	Roche's Genentech Expands Investment in North Carolina Facility to $2B (Zacks)
11:30AM	J&J's 2026 guidance driven by 'exciting' new product story (Yahoo Finance Video)
10:28AM	J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales (Zacks)
10:23AM	GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout (Zacks)
10:21AM	7 ETF Themes Investors Are Watching As The Fear & Greed Index Slips Toward Caution (Benzinga)
09:36AM	Stocks to Watch Wednesday: Netflix, J&J, United Airlines (The Wall Street Journal)
09:18AM	Johnson & Johnson Shares Fall Despite Q4 Revenue Beat (GuruFocus.com)
07:58AM	Earnings live: Netflix stock tumbles, Johnson & Johnson falls, Halliburton and United Airlines climb (Yahoo Finance)
07:56AM	Johnson & Johnson Expects 2026 Sales To Hit Almost $100 Billion (Benzinga)
07:26AM	J&J expects to hit $100 billion in revenue next year after new strategy pays off (MarketWatch)
07:07AM	Johnson & Johnson Earnings Beat Estimates. The Stock Is Falling. (Barrons.com)
06:29AM	Johnson & Johnson: Q4 Earnings Snapshot (Associated Press Finance)
06:20AM	Johnson & Johnson reports Q4 and Full-Year 2025 results (Business Wire)
06:20AM	J&J's Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales (The Wall Street Journal)
06:20AM	A Stock Slump Could Slam the Economy (The Wall Street Journal)
05:46AM	How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings (Benzinga)
05:25AM	Johnson & Johnson headlines earnings slate (MarketWatch)
05:16AM	Stock Market Today: Dow Jones, S&P 500 Futures Recover As Focus Turns To Trump's Davos Address-Johnson & Johnson, Intel, GameStop In Focus (Benzinga)
04:06AM	Trump at Davos, Intel Earnings, Supreme Court: What to Watch This Week (The Wall Street Journal)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Duato Joaquin	CEO and Chairman of the Board	Jan 26 '26	Sale	221.23	100,000	22,122,893	30,852	Jan 28 06:07 PM
Joaquin Duato	CEO, Chariman	Jan 26 '26	Proposed Sale	220.14	100,000	22,014,000		Jan 26 04:57 PM
MORIKIS JOHN G	Director	Nov 26 '25	Buy	206.15	1,250	257,688	1,849	Dec 01 04:15 PM
JOHNSON & JOHNSON	10% Owner	Nov 26 '25	Sale	10.03	6,337	63,560	4,040,861	Dec 01 04:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 24 '25	Sale	10.06	2,200	22,132	4,047,198	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 21 '25	Sale	10.00	500	5,000	4,049,398	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 12 '25	Sale	10.00	1,000	10,000	4,049,898	Nov 14 03:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 06 '25	Sale	10.21	52,332	534,310	4,051,098	Nov 10 03:28 PM
JOHNSON & JOHNSON	10% Owner	Nov 07 '25	Sale	10.00	200	2,000	4,050,898	Nov 10 03:28 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Option Exercise	157.92	21,721	3,430,180	32,379	Oct 20 07:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Sale	192.71	21,721	4,185,793	10,658	Oct 20 07:13 PM
REED JOHN C	Officer	Oct 17 '25	Proposed Sale	192.71	21,721	4,185,794		Oct 17 10:23 AM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Option Exercise	101.87	56,471	5,752,701	234,484	Sep 05 06:00 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Sep 04 '25	Sale	177.81	56,471	10,040,883	178,013	Sep 05 06:00 PM
Taubert Jennifer L	Officer	Sep 04 '25	Proposed Sale	177.81	56,471	10,040,904		Sep 04 02:37 PM
Forminard Elizabeth	Executive VP, General Counsel	Aug 29 '25	Option Exercise	115.67	11,521	1,332,634	22,423	Sep 03 05:13 PM
Forminard Elizabeth	Officer	Aug 29 '25	Proposed Sale	177.20	9,570	1,695,806		Aug 29 03:36 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Option Exercise	101.87	125,824	12,817,691	401,791	Aug 25 07:12 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 22 '25	Sale	179.21	125,824	22,548,655	275,967	Aug 25 07:12 PM
Duato Joaquin	Officer	Aug 22 '25	Proposed Sale	180.03	125,824	22,652,724		Aug 22 01:58 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Option Exercise	101.87	16,820	1,713,453	30,820	Aug 18 06:19 PM
Wolk Joseph J	Exec VP, CFO	Aug 15 '25	Sale	176.91	16,820	2,975,571	14,000	Aug 18 06:19 PM
Wolk Joseph J	Officer	Aug 15 '25	Proposed Sale	176.91	16,820	2,975,571		Aug 15 03:57 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Jul 17 '25	Sale	163.55	19,137	3,129,830	10,658	Jul 18 04:12 PM
REED JOHN C	Officer	Jul 17 '25	Proposed Sale	163.55	19,137	3,129,831		Jul 17 04:05 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '25	Option Exercise	0.00	25,255	0	40,797	May 05 05:10 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Option Exercise	101.87	6,999	712,988	28,000	Feb 26 06:42 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Sale	165.88	6,999	1,160,994	21,001	Feb 26 06:42 PM
Decker Robert J	Officer	Feb 25 '25	Proposed Sale	165.88	6,999	1,161,010		Feb 25 03:05 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	2,806	0	17,904	Feb 18 09:46 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '25	Option Exercise	0.00	1,029	0	15,501	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	1,765	0	15,111	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '25	Option Exercise	0.00	499	0	13,539	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '25	Sale	156.15	403	62,928	15,098	Feb 18 09:33 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '25	Option Exercise	0.00	607	0	91,037	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 14 '25	Option Exercise	0.00	7,367	0	96,674	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '25	Option Exercise	0.00	651	0	89,603	Feb 18 09:16 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '25	Option Exercise	0.00	1,971	0	6,113	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 14 '25	Option Exercise	0.00	19,330	0	20,661	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '25	Option Exercise	0.00	1,779	0	1,779	Feb 18 09:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '25	Option Exercise	0.00	1,350	0	15,927	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '25	Option Exercise	0.00	1,594	0	171,110	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 14 '25	Option Exercise	0.00	19,518	0	185,924	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '25	Option Exercise	0.00	1,302	0	167,221	Feb 18 09:08 PM
Swanson James D.	EVP, CIO	Feb 15 '25	Option Exercise	0.00	492	0	16,762	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 14 '25	Option Exercise	0.00	5,079	0	19,739	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 13 '25	Option Exercise	0.00	447	0	15,019	Feb 18 09:06 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '25	Option Exercise	0.00	419	0	13,095	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	2,608	0	14,576	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '25	Option Exercise	0.00	411	0	12,100	Feb 18 09:05 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 15 '25	Option Exercise	0.00	961	0	10,321	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 14 '25	Option Exercise	0.00	2,203	0	11,366	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '25	Option Exercise	0.00	651	0	8,991	Feb 18 09:03 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '25	Option Exercise	0.00	3,682	0	397,525	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 14 '25	Option Exercise	0.00	24,335	0	415,205	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '25	Option Exercise	0.00	3,470	0	392,498	Feb 18 09:02 PM
Decker Robert J	VP Corporate Controller	Feb 15 '25	Option Exercise	0.00	339	0	20,116	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 14 '25	Option Exercise	0.00	2,201	0	21,373	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 13 '25	Option Exercise	0.00	312	0	19,285	Feb 18 09:01 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '25	Option Exercise	0.00	492	0	21,839	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 14 '25	Option Exercise	0.00	4,740	0	24,591	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '25	Option Exercise	0.00	408	0	20,242	Feb 18 08:58 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 07 '25	Option Exercise	100.06	126,369	12,644,482	489,671	Feb 11 07:43 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 07 '25	Option Exercise	100.06	32,762	3,278,166	115,028	Feb 11 07:42 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 07 '25	Option Exercise	100.06	58,504	5,853,910	213,355	Feb 11 07:41 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Option Exercise	100.06	13,015	1,302,281	13,015	Feb 11 07:40 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Sale	153.89	13,015	2,002,878	0	Feb 11 07:40 PM
Wolk Joseph J	Officer	Feb 07 '25	Proposed Sale	153.89	13,015	2,002,924		Feb 07 01:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience